Nothing Special   »   [go: up one dir, main page]

EP3789043A4 - Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products - Google Patents

Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products Download PDF

Info

Publication number
EP3789043A4
EP3789043A4 EP19777982.0A EP19777982A EP3789043A4 EP 3789043 A4 EP3789043 A4 EP 3789043A4 EP 19777982 A EP19777982 A EP 19777982A EP 3789043 A4 EP3789043 A4 EP 3789043A4
Authority
EP
European Patent Office
Prior art keywords
extraction
herbal medicine
related products
plant source
manual preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19777982.0A
Other languages
German (de)
French (fr)
Other versions
EP3789043A1 (en
Inventor
Chengyu Jiang
Xiaoyun Li
Jianchao DU
Zhu Liang
Zhiqing Wang
Chenxuan WANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Basic Medical Sciences of CAMS
Original Assignee
Institute of Basic Medical Sciences of CAMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2018/081155 external-priority patent/WO2018177383A1/en
Application filed by Institute of Basic Medical Sciences of CAMS filed Critical Institute of Basic Medical Sciences of CAMS
Publication of EP3789043A1 publication Critical patent/EP3789043A1/en
Publication of EP3789043A4 publication Critical patent/EP3789043A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C07C225/06—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP19777982.0A 2018-03-29 2019-03-05 Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products Pending EP3789043A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2018/081155 WO2018177383A1 (en) 2017-03-29 2018-03-29 Application of compound or traditional chinese medicine extract in preparation of nucleic acid delivery agent and related products thereof
PCT/CN2019/077004 WO2019184663A1 (en) 2018-03-29 2019-03-05 Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products

Publications (2)

Publication Number Publication Date
EP3789043A1 EP3789043A1 (en) 2021-03-10
EP3789043A4 true EP3789043A4 (en) 2022-08-03

Family

ID=78822749

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19777982.0A Pending EP3789043A4 (en) 2018-03-29 2019-03-05 Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products

Country Status (4)

Country Link
US (1) US20210113641A1 (en)
EP (1) EP3789043A4 (en)
CN (1) CN111971072B (en)
WO (1) WO2019184663A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115671025A (en) * 2021-07-27 2023-02-03 中国医学科学院基础医学研究所 Application of FA lipid compound in preparation of nucleic acid delivery agent and related product thereof
CN113846098B (en) * 2021-09-18 2024-06-25 中国医学科学院基础医学研究所 Small RNA and application thereof in treatment of cardiovascular diseases
WO2024061211A1 (en) * 2022-09-20 2024-03-28 中国医学科学院基础医学研究所 Lipid compound for nucleic acid delivery, and related use and medicament comprising same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112730A2 (en) * 2011-02-15 2012-08-23 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
US20130315937A1 (en) * 2012-05-23 2013-11-28 The Ohio State University Lipid nanoparticle compositions for antisense oligonucleotides delivery
WO2016004318A1 (en) * 2014-07-02 2016-01-07 Shire Human Genetic Therapies, Inc. Encapsulation of messenger rna

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1897918A (en) * 2003-11-17 2007-01-17 阿尔萨公司 Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
EP3204032B1 (en) * 2014-10-10 2024-03-27 Massachusetts Eye & Ear Infirmary Chimeric molecule comprising crispr/cas or cas9 nuclease and at least one guide rna targeting pmca2 gene locus and fused, complexed or linked to an anionic fluorescent protein, and its use in the treatment of deafness or disorders thereof
CN105534908B (en) * 2016-01-15 2018-12-14 徐州医学院 A kind of tool Anaerobic response ability containing nucleic acid drug and radio therapy sensitization function liposome
MA49023A (en) * 2017-03-29 2020-02-05 Inst Basic Medical Sciences Cams APPLICATION OF A COMPOUND OR AN EXTRACT OF TRADITIONAL CHINESE MEDICINE IN THE PREPARATION OF AN AGENT FOR THE ADMINISTRATION OF NUCLEIC ACID AND CORRESPONDING RELATED PRODUCTS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112730A2 (en) * 2011-02-15 2012-08-23 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
US20130315937A1 (en) * 2012-05-23 2013-11-28 The Ohio State University Lipid nanoparticle compositions for antisense oligonucleotides delivery
WO2016004318A1 (en) * 2014-07-02 2016-01-07 Shire Human Genetic Therapies, Inc. Encapsulation of messenger rna

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DU JIANCHAO ET AL: "Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7", SCIENCE CHINA LIFE SCIENCES, 31 March 2017 (2017-03-31), pages 309 - 324, XP055860047, Retrieved from the Internet <URL:http://link.springer.com/article/10.1007/s11427-017-9026-7/fulltext.html> [retrieved on 20211110] *
DU JIANCHAO ET AL: "Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7", vol. 62, no. 3, 31 March 2017 (2017-03-31), pages 309 - 320, XP009531166, ISSN: 1674-7305, Retrieved from the Internet <URL:http://link.springer.com/article/10.1007/s11427-017-9026-7/fulltext.html> DOI: 10.1007/S11427-017-9026-7 *
LUKASIK ANNA ET AL: "Plant MicroRNAs-Novel Players in Natural Medicine?", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 1, 22 December 2016 (2016-12-22), pages 9, XP055901893, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297644/pdf/ijms-18-00009.pdf> DOI: 10.3390/ijms18010009 *
See also references of WO2019184663A1 *
SWARNLATA SARAF PROF ET AL: "Sphingosomes a novel appoach to vesicular drug delivery", 1 January 2011 (2011-01-01), XP055902930, Retrieved from the Internet <URL:https://www.researchgate.net/profile/Dr-Chanchal-Deep-Kaur/publication/215487283_Sphingosomes_a_novel_approach_to_vesicular_drug_delivery/links/00b4952be27eda30ba000000/Sphingosomes-a-novel-approach-to-vesicular-drug-delivery.pdf> [retrieved on 20220318] *
YANG CHUNHUA ET AL: "Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines", JOURNAL OF MATERIALS CHEMISTRY. B, vol. 6, no. 9, 29 January 2018 (2018-01-29), GB, pages 1312 - 1321, XP055899825, ISSN: 2050-750X, Retrieved from the Internet <URL:https://pubs.rsc.org/en/content/articlepdf/2018/tb/c7tb03207b> DOI: 10.1039/C7TB03207B *
ZHANG MINGZHEN ET AL: "Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis", NANOMEDICINE, vol. 12, no. 16, 1 August 2017 (2017-08-01), GB, pages 1927 - 1943, XP055858846, ISSN: 1743-5889, Retrieved from the Internet <URL:http://dx.doi.org/10.2217/nnm-2017-0196> DOI: 10.2217/nnm-2017-0196 *
ZHEN ZHOU ET AL: "Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses", CELL RESEARCH, vol. 25, no. 1, 1 January 2015 (2015-01-01), Singapore, pages 39 - 49, XP055247995, ISSN: 1001-0602, DOI: 10.1038/cr.2014.130 *

Also Published As

Publication number Publication date
US20210113641A1 (en) 2021-04-22
CN111971072B (en) 2023-06-13
CN111971072A (en) 2020-11-20
EP3789043A1 (en) 2021-03-10
WO2019184663A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
ZA202103074B (en) Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation
EP3854816A4 (en) Anti-b7h3 antibody-exatecan analog conjugate and medicinal use thereof
EP3789043A4 (en) Extraction of plant source &#34;medicinal soup&#34; and manual preparation of &#34;herbal medicine&#34; and related products
MX2019012081A (en) Human fibroblast growth factor 21 (hfgf21) fusion protein, preparation method therefor, and use thereof.
EP2278985A4 (en) Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same
EP3747446A4 (en) Uses of pulsatilla chinensis extract in preparing drug for treating viral and/or bacterial diseases
EP3744335A4 (en) Medicinal preparation and medical instrument
EP3178482A4 (en) Applications of phillyrin/phillygenin composition in preparing drugs or health care products for relieving and/or treating viral diseases
EP3682884A4 (en) Crystal form of gsk1278863 and preparation method and pharmaceutical use thereof
EP3572088A4 (en) Panax plant extract and pharmaceutical composition and use thereof
EP3604269A4 (en) Application of compound or traditional chinese medicine extract in preparation of nucleic acid delivery agent and related products thereof
EP3243517A4 (en) Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material
WO2016030644A3 (en) Method for inducing the synthesis of phycobiliproteins
EP3326640A4 (en) Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
EP3883548A4 (en) Methods of improving pharmaceutical substance solubilization and products thereof
IL288645A (en) Saponin conjugate and vaccine or pharmaceutical composition comprising the same
EP3524241A4 (en) Use of idhp in preparation of drug or health product for prevention and treatment of coronary atherosclerosis disease
EP3552612A4 (en) Pharmaceutical preparation and medical instrument
EP3880183A4 (en) Pharmaceutical preparation of fruquintinib and use thereof
EP3991723A4 (en) Pharmaceutical composition with improved stability comprising natural product extract
EP3835305A4 (en) Multifunctional immunity-targeted micromolecule anti-cancer medicine bestazomib (bestazomib) and preparation method and application thereof
EP3747896A4 (en) Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof
GB2576694B (en) Pharmaceutical product preparation device and method
EP3458058A4 (en) A pharmaceutical composition and the use thereof in the treatment of autoimmune diseases
WO2016175589A3 (en) Pharmaceutical composition for preventing or treating respiratory diseases, containing extract of mixed herbal medicines

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20220329BHEP

Ipc: A61K 47/46 20060101ALI20220329BHEP

Ipc: A61K 9/107 20060101ALI20220329BHEP

Ipc: A61K 48/00 20060101ALI20220329BHEP

Ipc: C07F 9/09 20060101ALI20220329BHEP

Ipc: C07C 233/00 20060101ALI20220329BHEP

Ipc: C07C 229/00 20060101ALI20220329BHEP

Ipc: C07C 219/00 20060101AFI20220329BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0048000000

Ipc: C07C0219000000

A4 Supplementary search report drawn up and despatched

Effective date: 20220705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20220629BHEP

Ipc: A61K 47/46 20060101ALI20220629BHEP

Ipc: A61K 9/107 20060101ALI20220629BHEP

Ipc: A61K 48/00 20060101ALI20220629BHEP

Ipc: C07F 9/09 20060101ALI20220629BHEP

Ipc: C07C 233/00 20060101ALI20220629BHEP

Ipc: C07C 229/00 20060101ALI20220629BHEP

Ipc: C07C 219/00 20060101AFI20220629BHEP